Liver Cancer Cell Lines
Database

LCCL to predict drug response

Drug: Selumetinib

DrugsAliasTargetsTargeted cellular functionClinical status in any tumor typeClinical status in HCCSupplierReference
Selumetinib AZD6244 MEK1/2 MAPK/ERK signaling Phase 1, 2 Phase 2 Selleck Chemicals S1008

Cell Line (34)
Cell LineAUCGI50
JHH10.640.235
HepaRG0.7310.0
HepG20.7510.0
SNU8780.756.727
JHH50.815.365
PLC.PRF50.8210.0
SNU3870.8710.0
HCC.1.20.889.725
Mahlavu0.8810.0
HCC.30.8910.0
SNU7390.8910.0
JHH70.910.0
Hep3B0.910.0
SNU4230.9110.0
SNU3680.9210.0


LCCL transcriptomic subgroup:
CL1
CL2
CL3
undef.

Codebase Soc. Coop.
info@codebase.it